Bayer Animal Health reveals new product
Bayer Animal Health is launching its most recent innovation, Credo D, made with DStar adjuvant, for control of darkling beetles in poultry operations.
Credo D contains DStar and imidacloprid (a chloronicotinyl insecticide); a formulation developed by Bayer Animal Health for effective control of darkling beetles. Credo D with DStar contains a proprietary adjuvant and offers more control of both larval and adult darkling beetles compared to other imidacloprid products.
"Credo D with DStar is an effective new tool for long growth in poultry operations," said Dr Doug Ross, Manager of Clinical Development Projects for Bayer Animal Health. "We invested research and development resources into this product because the industry told us there was a real need for a solution to the darkling beetle problem. We are proud to say Credo D with DStar is that solution."
The latest research demonstrates the excellent performance of Credo D with DStar on darkling beetles in long grow out conditions. In a study at a North Carolina broiler farm, at the conclusion of the 59-day grow out, the number of adult and larval darkling beetles in a house treated with Credo D with DStar were nearly 50% less compared to a house treated with Credo SC Insecticide. In another study at a North Carolina turkey brooder farm, poultry houses treated with Credo D with DStar had the lowest average adult beetle count five weeks following treatment.
Darkling beetles have long been a serious problem for the poultry industry â€” spreading disease, destroying insulation and consuming poultry feed, which ultimately means eating away profits. Credo D with DStar also serves as a resistance management tool for poultry houses when rotated with Tempo products.
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR16.913 billion (US$24.4 billion) last year, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide.